Pressroom

See all trending topics »Trending Topics

Check out the latest cancer-related news and also see who is readily available to offer reliable information, expert commentary, and reaction to today's headlines.
Contact a media coordinator »

Exciting Developments, New Research in Breast Cancer: San Antonio Breast Cancer Symposium

Memorial Sloan Kettering breast cancer experts are available to comment on breaking news out of this year’s annual meeting set to take place December 9 through 13.

Monday, December 8, 2014
Major Developments in Hematology-Oncology to Be Reported at ASH Annual Meeting

The largest hematology-oncology meeting in the world will take place in San Francisco from December 6 through 9. Memorial Sloan Kettering experts are available to comment on breaking news out of the meeting.

Tuesday, December 2, 2014
Memorial Sloan Kettering Team Makes Key Discovery in Understanding Immunotherapy’s Successes—And Its Failures

A collaborative team of leaders in the field of cancer immunology has made a key discovery that advances the understanding of why some patients respond to ipilimumab, an immunotherapy drug, while others do not.

Wednesday, November 19, 2014

See all press releases »Press Releases

Memorial Sloan Kettering Debuts New Mobile Application for Patients

Memorial Sloan Kettering Cancer Center (MSK) has debuted MyMSK, a new mobile application. The app, compatible with iPad, iPhone, and all iOS devices, allows MSK patients to quickly and easily access their lab and radiology results, view their upcoming appointments, record their medications and symptoms in online diaries, communicate with their healthcare team, and more.

Monday, February 23, 2015
Memorial Sloan Kettering Cancer Center and Weill Cornell to Co-Lead Tuberculosis Research Unit

In an effort to stop tuberculosis (TB) from becoming progressively less treatable worldwide, the National Institutes of Health is funding a research collaboration among six institutions in close alliance. The total funding, provided by the National Institute of Allergy and Infectious Diseases, could be up to $45.7 million over seven years.

Wednesday, February 18, 2015
Pictured: Eytan Stein
Memorial Sloan Kettering Study Shows New Kind of Targeted Drug Has Promise for Leukemia Patients

A new type of cancer therapy that targets an oncometabolite produced dramatic results in patients with advanced leukemia in an early-phase clinical trial.

Sunday, December 7, 2014

See all blog posts »On Our Blog

Pictured: Teresa Gilewski and filmmaker Barak Goodman
Event
Considering the Human Side — and the History — of Cancer

MSK employees previewed the upcoming documentary Cancer: The Emperor of All Maladies, which features several of our scientists and their research.

Thursday, March 26, 2015
Megan Harlan Fleischut and Kenneth Offit
Q & A
Why Might A Woman Have Her Ovaries Removed?

Women can use the results of genetic tests to make informed decisions about ovary removal to reduce cancer risk.

Tuesday, March 24, 2015
Exceptional responders of new drugs in clinical trials.
Decoder
What Are Exceptional Responders?

When a clinical trial of a new drug fails because most patients don’t respond, progress can still be made by analyzing the tumors of the rare patients who benefit.

Tuesday, March 24, 2015

MSK News Highlights

Watch highlights including news coverage of recent scientific and clinical developments at Memorial Sloan Kettering, our physicians and scientists in the national spotlight, and our amazing staff and programs.

Watch Video »

See all media coverage »Media Coverage

Plant-Based Diet, with Fish, May Lower Risk of Colorectal Cancer

Medical oncologist Leonard Saltz discusses how a plant-based diet may lower the risk of colorectal cancers in Reuters.

Tuesday, March 10, 2015
W-CBS News

Medical oncologist Ross Levine discusses the importance of Cycle for Survival for W-CBS News.

Sunday, March 8, 2015
TIME

Neurosurgeon Philip Gutin and anesthesiologist Paul Dalecki were profiled in a Time.com video about awake brain surgery at MSK.

Saturday, March 7, 2015

For Journalists

Contact Media Staff

Jeanne D'Agostino
Media Relations Manager
Emily O'Donnell
Senior Communications Associate, Department of Surgery
Courtney Nowak
Senior Media Relations Associate
Caitlin Hool
Senior Media Associate
Nicole H. McNamara
Senior Media Relations Associate
Rebecca Williams
Media Associate

For press inquiries, our Media Staff are available by calling 646-227-3573 or by dialing the numbers above. Our office hours are Monday - Friday, 9:00 AM to 5:00 PM.

After hours, please contact the hospital's page operator at 212-639-7900 and ask for the Public Affairs representative on-call.

#1 in Cancer Care

MSK Named #1 by U.S. News

News & World Report named Memorial Sloan Kettering the top hospital for cancer care in the nation. We're honored, and patient care will always be our top priority.

Live and Remote Broadcast Capabilities

Our experts can offer live broadcast interviews using the on-site studio system. To book an expert interview using our on-site broadcast studio contact our Media Staff.

Subscribe to Our
E-Newsletter

Our e-mail newsletter for journalists offers the latest advances in cancer research and treatment, including story ideas, institutional milestones and plans, and newsworthy staff accomplishments.

Sign Up

Read recent issues »